These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23469136)

  • 1. Stimulation of inositol 1,4,5-trisphosphate (IP3) receptor subtypes by adenophostin A and its analogues.
    Saleem H; Tovey SC; Riley AM; Potter BV; Taylor CW
    PLoS One; 2013; 8(2):e58027. PubMed ID: 23469136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective determinants of inositol 1,4,5-trisphosphate and adenophostin A interactions with type 1 inositol 1,4,5-trisphosphate receptors.
    Rossi AM; Sureshan KM; Riley AM; Potter VL; Taylor CW
    Br J Pharmacol; 2010 Nov; 161(5):1070-85. PubMed ID: 20977457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of inositol 1,4,5-trisphosphate (IP3) receptor subtypes by analogues of IP3.
    Saleem H; Tovey SC; Rahman T; Riley AM; Potter BV; Taylor CW
    PLoS One; 2013; 8(1):e54877. PubMed ID: 23372785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of phosphates and adenine to the potency of adenophostins at the IP₃ receptor: synthesis of all possible bisphosphates of adenophostin A.
    Sureshan KM; Riley AM; Thomas MP; Tovey SC; Taylor CW; Potter BV
    J Med Chem; 2012 Feb; 55(4):1706-20. PubMed ID: 22248345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triazolophostins: a library of novel and potent agonists of IP3 receptors.
    Vibhute AM; Konieczny V; Taylor CW; Sureshan KM
    Org Biomol Chem; 2015 Jun; 13(24):6698-710. PubMed ID: 25869535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional inositol 1,4,5-trisphosphate receptors assembled from concatenated homo- and heteromeric subunits.
    Alzayady KJ; Wagner LE; Chandrasekhar R; Monteagudo A; Godiska R; Tall GG; Joseph SK; Yule DI
    J Biol Chem; 2013 Oct; 288(41):29772-84. PubMed ID: 23955339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of inositol 1,4,5-trisphosphate (IP
    Chandran A; Chee X; Prole DL; Rahman T
    Sci Rep; 2019 Feb; 9(1):2454. PubMed ID: 30792485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenine-nucleotide binding sites on the inositol 1,4,5-trisphosphate receptor bind caffeine, but not adenophostin A or cyclic ADP-ribose.
    Maes K; Missiaen L; Parys JB; Sienaert I; Bultynck G; Zizi M; De Smet P; Casteels R; De Smedt H
    Cell Calcium; 1999 Feb; 25(2):143-52. PubMed ID: 10326681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of antagonists with subtypes of inositol 1,4,5-trisphosphate (IP3) receptor.
    Saleem H; Tovey SC; Molinski TF; Taylor CW
    Br J Pharmacol; 2014 Jul; 171(13):3298-312. PubMed ID: 24628114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 and IP
    Ivanova H; Wagner LE; Tanimura A; Vandermarliere E; Luyten T; Welkenhuyzen K; Alzayady KJ; Wang L; Hamada K; Mikoshiba K; De Smedt H; Martens L; Yule DI; Parys JB; Bultynck G
    Cell Mol Life Sci; 2019 Oct; 76(19):3843-3859. PubMed ID: 30989245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designer small molecules to target calcium signalling.
    Swarbrick JM; Riley AM; Mills SJ; Potter BV
    Biochem Soc Trans; 2015 Jun; 43(3):417-25. PubMed ID: 26009185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoform- and species-specific control of inositol 1,4,5-trisphosphate (IP3) receptors by reactive oxygen species.
    Bánsághi S; Golenár T; Madesh M; Csordás G; RamachandraRao S; Sharma K; Yule DI; Joseph SK; Hajnóczky G
    J Biol Chem; 2014 Mar; 289(12):8170-81. PubMed ID: 24469450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique Regulatory Properties of Heterotetrameric Inositol 1,4,5-Trisphosphate Receptors Revealed by Studying Concatenated Receptor Constructs.
    Chandrasekhar R; Alzayady KJ; Wagner LE; Yule DI
    J Biol Chem; 2016 Mar; 291(10):4846-60. PubMed ID: 26755721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-dependent adenophostin activation of inositol 1,4,5-trisphosphate receptor channel gating: kinetic implications for the durations of calcium puffs in cells.
    Mak DO; McBride S; Foskett JK
    J Gen Physiol; 2001 Apr; 117(4):299-314. PubMed ID: 11279251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural determinants of adenophostin A activity at inositol trisphosphate receptors.
    Correa V; Riley AM; Shuto S; Horne G; Nerou EP; Marwood RD; Potter BV; Taylor CW
    Mol Pharmacol; 2001 May; 59(5):1206-15. PubMed ID: 11306705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of inositol 1,4,5-trisphosphate (IP3) and adenophostin A to the N-terminal region of the IP3 receptor: thermodynamic analysis using fluorescence polarization with a novel IP3 receptor ligand.
    Ding Z; Rossi AM; Riley AM; Rahman T; Potter BV; Taylor CW
    Mol Pharmacol; 2010 Jun; 77(6):995-1004. PubMed ID: 20215561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Position base-modified analogues of adenophostin A as high-affinity agonists of the D-myo-inositol trisphosphate receptor: in vitro evaluation and molecular modeling.
    Sureshan KM; Trusselle M; Tovey SC; Taylor CW; Potter BV
    J Org Chem; 2008 Mar; 73(5):1682-92. PubMed ID: 18247493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: recognition by cerebellar and platelet inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Riley AM; Lindley CJ; Jenkins DJ; Westwick J; Potter BV
    Mol Pharmacol; 1997 Oct; 52(4):741-8. PubMed ID: 9380038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of IP3 receptors in and out of cells.
    Rossi AM; Tovey SC; Rahman T; Prole DL; Taylor CW
    Biochim Biophys Acta; 2012 Aug; 1820(8):1214-27. PubMed ID: 22033379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fluorescence-based method for evaluating inositol 1,4,5-trisphosphate receptor ligands: determination of subtype selectivity and partial agonist effects.
    Tanimura A; Mochizuki T; Morita T; Nezu A; Tojyo Y; Arisawa M; Shuto S
    J Biotechnol; 2013 Sep; 167(3):248-54. PubMed ID: 23830902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.